Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 531

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection

Open access
Rubinstein, Natalia, Alvarez, Mariano, Zwirner, Norberto W, Toscano, Marta A, Ilarregui, Juan M, Bravo, Alicia, Mordoh, José, Fainboim, Leonardo, Podhajcer, Osvaldo L, Rabinovich, Gabriel A·2004·Cancer Cell
DOI 10.1016/s1535-6108(04)00024-8
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(04)00024-8

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 55

  1. Andreola, 2002, Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles, J. Exp. Med., 195, 1303, 10.1084/jem.20011624 · DOI · Paper page
  2. Blaser, 1998, β-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells, Eur. J. Immunol., 28, 2311, 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G · doi:10.1002/(sici)1521-4141(199808)28:08<2311::aid-immu2311>3.0.co;2-g
  3. Boon, 2003, Tumor immunology, Curr. Opin. Immunol., 15, 129, 10.1016/S0952-7915(03)00010-4 · DOI
  4. Camby, 2001, Galectins are differentially expressed in supratentorial pilocytic astrocytomas, anaplastic astrocytomas and glioblastomas and significantly modulate tumor astrocyte migration, Brain Pathol., 11, 12, 10.1111/j.1750-3639.2001.tb00377.x · DOI · Paper page
  5. Cheng, 2003, A critical role for Stat3 signaling in immune tolerance, Immunity, 19, 425, 10.1016/S1074-7613(03)00232-2 · DOI · Paper page
  6. Chung, 2000, Galectin-1 induces partial TCR ξ-chain phosphorylation and antagonizes processive TCR signal transduction, J. Immunol., 165, 3722, 10.4049/jimmunol.165.7.3722 · DOI · Paper page
  7. Cindolo, 1999, Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas, Cancer, 84, 39
  8. Daniels, 2002, Sweet `n' sour, Nat. Immunol., 3, 903, 10.1038/ni1002-903 · DOI · Paper page
  9. Dias-Baruffi, 2003, Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis, J. Biol. Chem., 278, 41282, 10.1074/jbc.M306624200 · DOI · Paper page
  10. Dong, 2002, Tumor-associated B7–H1 promotes T-cell apoptosis, Nat. Med., 8, 793, 10.1038/nm0902-1039c · DOI · Paper page
  11. Duguay, 2002, In vivo IRF-3 tumor suppressor activity in B16 melanoma tumors, Cancer Res., 62, 5148
  12. Dunn, 2002, Cancer immunoediting, Nat. Immunol., 3, 991, 10.1038/ni1102-991 · DOI · Paper page
  13. Feizi, 2000, Progress in deciphering the information content of the glycome, Glycoconj. J., 17, 553, 10.1023/A:1011022509500 · DOI
  14. Friberg, 2002, Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T-cell-mediated rejection, Int. J. Cancer, 101, 151, 10.1002/ijc.10645 · DOI · Paper page
  15. Fukumori, 2003, CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis, Cancer Res., 63, 8302
  16. Ghosh, 1995, Gradual loss of T-helper 1 populations in spleens of mice during progressive tumor growth, J. Natl. Cancer Inst., 87, 1478, 10.1093/jnci/87.19.1478 · DOI
  17. Green, 2001, The role of Fas ligand in immune privilege, Nat. Rev. Mol. Cell Biol., 2, 917, 10.1038/35103104 · DOI · Paper page
  18. Guerra, 1989, Characterization of IIB-Mel-J, Pigment Cell Res., 2, 504, 10.1111/j.1600-0749.1989.tb00246.x · doi:10.1111/j.1600-0749.1989.tb00246.x
  19. Hahne, 1996, Melanoma cell expression of Fas (Apo-1/CD95) ligand, Science, 274, 1363, 10.1126/science.274.5291.1363 · DOI · Paper page
  20. Hu, 1998, Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type-2 to a type-1 cytokine profile, J. Immunol., 161, 3033, 10.4049/jimmunol.161.6.3033 · DOI
  21. Igney, 2002, Immune escape of tumors, J. Leukoc. Biol., 71, 907, 10.1189/jlb.71.6.907 · DOI · Paper page
  22. Kariyama, 1995, Biologic, immunocytochemical and cytogenetic characterization of two new melanoma cell lines, Pigment Cell Res., 8, 121, 10.1111/j.1600-0749.1995.tb00652.x · doi:10.1111/j.1600-0749.1995.tb00652.x
  23. Kelly, 2002, Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection, Nat. Immunol., 3, 83, 10.1038/ni746 · DOI · Paper page
  24. Kopitz, 2001, Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3, J. Biol. Chem., 276, 35917, 10.1074/jbc.M105135200 · DOI · Paper page
  25. Lahm, 2001, Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic purposes, J. Cancer Res. Clin. Oncol., 127, 375, 10.1007/s004320000207 · DOI · Paper page
  26. Ledda, 1997, Supression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells, Nat. Med., 3, 171, 10.1038/nm0297-171 · DOI · Paper page
  27. Liu, 2000, Galectins, Clin. Immunol., 97, 79, 10.1006/clim.2000.4912 · DOI · Paper page
  28. Lowe, 2001, Glycosylation, immunity and autoimmunity, Cell, 104, 809, 10.1016/S0092-8674(01)00277-X · DOI · Paper page
  29. Marincola, 2000, Escape of human solid tumors from T-cell recognition, Adv. Immunol., 74, 181, 10.1016/S0065-2776(08)60911-6 · DOI · Paper page
  30. Morvillo, 1996, Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-Mel-J, a human melanoma cell line, Cell Mol. Biol., 42, 779
  31. Nguyen, 2001, CD45 modulates galectin-1-induced T cell death, J. Immunol., 167, 5697, 10.4049/jimmunol.167.10.5697 · DOI · Paper page
  32. O'Connell, 2001, Immune privilege or inflammation? Insights into the Fas ligand enigma, Nat. Med., 7, 271, 10.1038/85395 · DOI
  33. Pardoll, 2002, Spinning molecular immunology into successful immunotherapy, Nat. Rev. Immunol., 2, 227, 10.1038/nri774 · DOI · Paper page
  34. Pardoll, 2003, Does the immune system see tumors as foreign or self?, Annu. Rev. Immunol., 21, 807, 10.1146/annurev.immunol.21.120601.141135 · DOI · Paper page
  35. Perillo, 1995, Apoptosis of T cells mediated by galectin-1, Nature, 378, 736, 10.1038/378736a0 · DOI · Paper page
  36. Rabinovich, 1999, Galectins, Cell Death Differ., 6, 711, 10.1038/sj.cdd.4400535 · DOI · Paper page
  37. Rabinovich, 1998, Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells, J. Immunol., 160, 4831, 10.4049/jimmunol.160.10.4831 · DOI · Paper page
  38. Rabinovich, 1999, Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis, J. Exp. Med., 190, 385, 10.1084/jem.190.3.385 · DOI · Paper page
  39. Rabinovich, 1999, Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1, Immunology, 97, 100, 10.1046/j.1365-2567.1999.00746.x · DOI · Paper page
  40. Rabinovich, 2002, Galectins and their ligands, Trends Immunol., 23, 313, 10.1016/S1471-4906(02)02232-9 · DOI · Paper page
  41. Rabinovich, 2002, Induction of allogeneic T-cell hyporesponsiveness by a galectin-1-mediated apoptotic and non-apoptotic mechanisms, Cell Death Differ., 9, 661, 10.1038/sj.cdd.4401009 · DOI
  42. Ramirez-Montagut, 2003, Immunity to melanoma, Oncogene, 22, 3180, 10.1038/sj.onc.1206462 · DOI
  43. Restifo, 2001, Countering the “counterattack” hypothesis, Nat. Med., 7, 259, 10.1038/85357 · DOI
  44. Sanjuan, 1997, Differential expression of galectin-3 and galectin-1 in colorectal cancer progression, Gastroenterology, 113, 1906, 10.1016/S0016-5085(97)70010-6 · doi:10.1016/s0016-5085(97)70010-6
  45. Santucci, 2003, Galectin-1 suppresses experimental colitis in mice, Gastroenterology, 124, 1381, 10.1016/S0016-5085(03)00267-1 · DOI · Paper page
  46. Shankaran, 2001, IFN-γ and lymphocytes prevent primary tumor development and shape tumor immunogenicity, Nature, 410, 1107, 10.1038/35074122 · DOI · Paper page
  47. Simon, 2002, Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies, Cancer Cell, 2, 315, 10.1016/S1535-6108(02)00151-4 · DOI
  48. Smyth, 2001, A fresh look at tumor immunosurveillance and immunotherapy, Nat. Immunol., 2, 293, 10.1038/86297 · DOI · Paper page
  49. Tinari, 2001, Glycoprotein 90K/Mac-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation, Int. J. Cancer, 91, 167, 10.1002/1097-0215(200002)9999:9999<::AID-IJC1022>3.3.CO;2-Q · DOI
  50. Trapani, 2002, Tumor-mediated apoptosis of cancer-specific T lymphocytes. Reversing the “kiss of death”?, Cancer Cell, 2, 169, 10.1016/S1535-6108(02)00130-7 · DOI
  51. van den Brule, 1995, Galectin-1 modulates human melanoma cell adhesion to laminin, Biochem. Biophys. Res. Commun., 209, 760, 10.1006/bbrc.1995.1564 · doi:10.1006/bbrc.1995.1564
  52. van den Brule, 2001, Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients, J. Pathol., 193, 80, 10.1002/1096-9896(2000)9999:9999<::AID-PATH730>3.0.CO;2-2 · doi:10.1002/1096-9896(2000)9999:9999<::aid-path730>3.0.co;2-2
  53. van den Brule, 2003, Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin, Lab. Invest., 83, 377, 10.1097/01.LAB.0000059949.01480.40 · DOI · Paper page
  54. Whiteside, 2002, Tumor-induced death of immune cells, Semin. Cancer Biol., 12, 43, 10.1006/scbi.2001.0402 · DOI
  55. Xu, 1995, Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications, Am. J. Pathol., 147, 815

Cited by

See all 531

Metadata

Authors
Rubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A., Ilarregui, J. M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O. L., & Rabinovich, G. A.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2004-03
Volume
5
Issue
3
Pages
241-251
ISSN
1535-6108 (ISSN-L)
DOI
10.1016/s1535-6108(04)00024-8
OpenAlex
W1968091639
Cited by
531
References
6
FWCI
12.68
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection. https://app.cochat.ai/papers/10.1016/s1535-6108(04)00024-8
The paper
Rubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A., Ilarregui, J. M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O. L., & Rabinovich, G. A. (2004). Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection. Cancer Cell. https://doi.org/10.1016/s1535-6108(04)00024-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.